Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Hospitals, Leicester

About this trial

Patients who are very ill either due to a severe infection, major organ injury, trauma or a major operation may require significant support with devices such as a dialysis machine for the kidneys or Extracorporeal Membrane Oxygenation (ECMO) for the heart and lungs. This is often due to a reaction of the body to the insult which is termed inflammation. The investigators would like to assess if the use of a device that can remove the agents driving this reaction can lead to a quicker recovery form the illness. The device is a blood filter called HA380 and it would be connected to either the dialysis machine or the ECMO circuit. The investigators want to assess the feasibility of conducting a study with the HA380 column. We will also evaluate if the use of the HA380 column has an effect on the time spent on dialysis or ECMO, time spent on the breathing machine, time spent requiring drugs to support blood pressure and time spent in the intensive care unit.

Eligibility criteria

Qualifiers

Consent obtained

Male or Female, aged 18 years - 65 years.

Admitted with a diagnosis of sepsis (according to sepsis-3 definition), trauma, ARDS of infectious or non-infectious aetiology, trauma or after major surgery

Need for extracorporeal support and specifically renal replacement therapy (RRT) and/or ECMO.

Disqualifiers

Unable to obtain consent.

Expected to die in the next 24 hours.

Pre-existing chronic kidney disease - requiring dialysis /eGFR < 30ml/min/1.73m2

Pre-existing severe respiratory failure - e.g., requiring home oxygen/ home nebulisers/ poor exercise tolerance

Trial design

Treatments tested in this trial

  • HA 380

Treatment groups

40 Participants
are divided into 2 treatment groups